Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Jul 25, 2022

SELL
$4.66 - $13.96 $10,252 - $30,712
-2,200 Closed
0 $0
Q3 2021

Oct 22, 2021

SELL
$27.38 - $42.21 $227,254 - $350,343
-8,300 Reduced 79.05%
2,200 $72,000
Q2 2021

Jul 26, 2021

BUY
$26.34 - $46.62 $26,340 - $46,620
1,000 Added 10.53%
10,500 $303,000
Q1 2021

Apr 23, 2021

SELL
$45.96 - $68.02 $363,084 - $537,358
-7,900 Reduced 45.4%
9,500 $481,000
Q4 2020

Jan 25, 2021

SELL
$13.72 - $51.57 $17,836 - $67,041
-1,300 Reduced 6.95%
17,400 $844,000
Q3 2020

Dec 14, 2020

SELL
$10.54 - $18.47 $75,888 - $132,984
-7,200 Reduced 27.8%
18,700 $330,000
Q2 2020

Jul 23, 2020

BUY
$10.37 - $20.64 $21,777 - $43,344
2,100 Added 8.82%
25,900 $471,000
Q2 2019

Jul 25, 2019

BUY
$14.61 - $22.45 $321,420 - $493,900
22,000 Added 1222.22%
23,800 $377,000
Q3 2018

Oct 19, 2018

BUY
$13.39 - $26.25 $24,102 - $47,250
1,800 New
1,800 $46,000

Others Institutions Holding SRRK

About Scholar Rock Holding Corp


  • Ticker SRRK
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 51,640,600
  • Market Cap $2.17B
  • Description
  • Scholar Rock Holding Corporation, a biopharmaceutical company, focuses on the discovery and development of medicines for the treatment of serious diseases in which signaling by protein growth factors plays a fundamental role. The company develops Apitegromab, an inhibitor of the activation of latent myostatin that has completed the Phase 3 clini...
More about SRRK
Track This Portfolio

Track Strs Ohio Portfolio

Follow Strs Ohio and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Strs Ohio, based on Form 13F filings with the SEC.

News

Stay updated on Strs Ohio with notifications on news.